Low FODMAP diet trial for IBS without lactose intolerance
Part of Digestive system clinical trials.
This trial tests whether eating a low-FODMAP diet can reduce IBS symptoms in people who do not have lactose intolerance. It aims to improve moderate-to-severe IBS symptoms by changing what kinds of carbohydrates you eat.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 75 years old
- Have IBS that meets Rome IV symptom criteria
- Have moderate-to-severe IBS symptoms (IBS symptom score over 175)
- You currently eat foods that contain lactose (like milk or ice cream)
- You should NOT have known lactose intolerance or any known inflammatory bowel disease
- You should not have had low-FODMAP or “LFD” diet in the past
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a breath test (hydrogen/methane lactose testing) can predict who with IBS will improve on a lactose-free diet. If you have moderate-to-severe IBS and regularly eat lactose-containing foods, the test result may help tailor your diet approach.
This trial studies whether a specific diet plan delivered through a phone app (the DOMINO diet) can improve symptoms in people with irritable bowel syndrome (IBS). It may help by changing what you eat to reduce gut symptoms, compared with standard care rules in the study.
This trial tests whether a low-FODMAP diet (a diet that avoids certain carbohydrates that can cause bloating and gas) can improve gut health in people with Irritable Bowel Syndrome. If you have IBS, this diet might help reduce your symptoms and improve how well your intestines work.
This study compares two diet plans for people with irritable bowel syndrome (IBS): a personalized diet tailored to your specific triggers and the low FODMAP diet, which avoids certain carbohydrates that can cause gas and bloating. The goal is to see which approach works better for relieving symptoms.
This trial tests whether a fecal microbiota transplantation (FMT), which transfers healthy bacteria from a donor into your gut, can reduce severe irritable bowel syndrome (IBS) symptoms. FMT is being studied as a possible new treatment for people with IBS that hasn't improved with other treatments.
This study looks at how lactose intolerance relates to irritable bowel syndrome (IBS) in people who already have both. It may help doctors understand the link and improve treatment. Participants will have their lactose digestion checked with special breath tests.
Hear when a new Irritable Bowel Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.